We acknowledge support from the Netherlands CardioVascular Research Initiative (CVON-PREDICT project, CVON 2012-10)
Our passion is helping people on their weight loss journey with everything from free resources like this to prescriptions and ongoing guidance
Talk about all of this with your healthcare provider to find the best option for you
In August 2025, Eli Lilly announced that its experimental oral GLP-1 orforglipron achieved better weight loss and blood sugar control than oral semaglutide in a head-to-head late-stage trial
She added she was "so skinny" but felt so ill that she couldn't throw a ball with her son
Adv Ther 40:51025114 Candido R, Gaiotti S, Giudici F, Toffoli B, De Luca F, Velardi V, Petrucco A, Gottardi C, Manca E, Buda I, Fabris B, Bernardi S (2023) Real-world retrospective study into the effects of oral semaglutide (as a switchover or add-on therapy) in type 2 diabetes